January 24, 2026
Evidence-Based Medicine for Better Fertility Outcomes
Evidence-based medicine reduces IVF cycles, lowers multiple pregnancy risks, and prioritizes genetic testing for embryo selection, with 52% of under-35 patients opting for elective single embryo transfers (eSET) at Shady Grove Fertility.
Key Takeaways
Genetic Testing (PGS/PGD) for Viable Embryo Selection in IVF
Preimplantation genetic screening (PGS) and diagnosis (PGD) are critical for identifying embryos with the highest potential for successful implantation, reducing the need for multiple IVF cycles and minimizing twin/triplet pregnancy risks.
Elective Single Embryo Transfers (eSET) to Reduce Multiple Pregnancy Risks
Transferring a single embryo (eSET) is recommended for most patients, with 52% of under-35 patients at Shady Grove Fertility using this method to prioritize maternal and infant health over multiple births.
Avoid Unproven Embryo Selection Methods Like Shape and Rigidity Analysis
Alternative techniques such as evaluating embryo shape or rigidity lack sufficient clinical evidence. Genetic testing remains the gold standard, though these methods may eventually complement expert embryologist assessments.
Optimizing Fertility Treatments Through Medication Adjustments and Protocol Customization
Tailoring treatment protocols, including adjusting medications and timing frozen embryo transfers (FET) when progesterone levels are optimal, enhances pregnancy success rates.
Leveraging Clinical Research and Data to Enhance IVF Success Rates
Ongoing research at fertility centers like Shady Grove Fertility focuses on refining IVF techniques, with a commitment to evidence-based practices that improve outcomes while reducing emotional and financial strain on patients.
Source: Read full article